A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
A National Institutes of Health working group urges the agency to send most of its chimpanzees to a national sanctuary and halt half of the experiments involving such animals.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.
A drug applied to the ears of deaf mice has prompted the regrowth of noise-damaged hair cells and resulted in slight improvements in the animals’ hearing.
Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
